DENTSPLY SIRONA Inc. (XRAY) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
XRAY Revenue Growth
Revenue Breakdown (FY 2022)
XRAY's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
XRAY Revenue Analysis (2014–2025)
As of May 8, 2026, DENTSPLY SIRONA Inc. (XRAY) generated trailing twelve-month (TTM) revenue of $3.68 billion, reflecting modest growth of +0.1% year-over-year. The most recent quarter (Q1 2026) recorded $880.0 million in revenue, down 8.4% sequentially.
Looking at the longer-term picture, XRAY's 5-year compound annual growth rate (CAGR) stands at +2.0%, indicating moderate growth over time. The company achieved its highest annual revenue of $4.23 billion in 2021.
Revenue diversification analysis shows XRAY's business is primarily driven by Technologies And Equipment (59%), and Consumables Segment (41%). With over half of revenue concentrated in Technologies And Equipment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ALGN (+2.9% YoY), HSIC (+4.0% YoY), and NVST (+12.1% YoY), XRAY has underperformed the peer group in terms of revenue growth. Compare XRAY vs ALGN →
XRAY Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XRAYCurrent | $3.7B | +0.1% | +2.0% | 6.8% | |
 ALGN | $4.0B | +2.9% | +10.3% | 15.3% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 NVST | $2.7B | +12.1% | +7.1% | 8.3% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
XRAY Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.68B | -3.0% | $1.84B | 50.0% | $252.0M | 6.8% |
| 2024 | $3.79B | -4.3% | $1.96B | 51.6% | $-879,000,000 | -23.2% |
| 2023 | $3.96B | +1.1% | $2.09B | 52.6% | $-85,000,000 | -2.1% |
| 2022 | $3.92B | -7.3% | $2.13B | 54.2% | $-937,000,000 | -23.9% |
| 2021 | $4.23B | +26.7% | $2.35B | 55.5% | $608.0M | 14.4% |
| 2020 | $3.34B | -17.0% | $1.66B | 49.6% | $-3,000,000 | -0.1% |
| 2019 | $4.02B | +0.9% | $2.16B | 53.8% | $353.0M | 8.8% |
| 2018 | $3.99B | -0.2% | $2.07B | 51.9% | $-958,100,000 | -24.0% |
| 2017 | $3.99B | +6.6% | $2.19B | 54.8% | $-1,585,300,000 | -39.7% |
| 2016 | $3.75B | +40.0% | $2.00B | 53.4% | $454.7M | 12.1% |
See XRAY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XRAY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XRAY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXRAY — Frequently Asked Questions
Quick answers to the most common questions about buying XRAY stock.
Is XRAY's revenue growth accelerating or slowing?
XRAY revenue growth slowed to +0.1%, below the 5-year CAGR of +2.0%. TTM revenue is $3.7B. The deceleration marks a shift from historical growth rates.
What is XRAY's long-term revenue growth rate?
DENTSPLY SIRONA Inc.'s 5-year revenue CAGR of +2.0% reflects the variable expansion pattern. Current YoY growth of +0.1% is near this long-term average.
How is XRAY's revenue distributed by segment?
XRAY reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.